Spanish Linguistic Validation, Validity and Reliability Test of Frail´BESTest in Elderly Institutionalized Frail People
Launched by INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN · May 27, 2024
Trial Information
Current as of February 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool called the Frail'BESTest, which is designed to assess balance in older adults who may be frail or have mild cognitive impairment. The goal is to identify balance issues early so that specific help can be provided to reduce the risk of falls, which can be very dangerous for elderly individuals. The study is taking place in Aragón, where a significant portion of the population is over 65 years old and facing challenges related to aging.
To participate, individuals should be able to stand for at least 10 seconds without assistance and meet certain criteria for frailty and cognitive status. Specifically, those who score 3 or higher on a frailty assessment will be considered frail, while those with mild cognitive impairment will also be included. However, individuals with severe cognitive issues or specific health conditions that prevent them from participating will not be eligible. Participants can expect to be involved in evaluations that help researchers understand how well the Frail'BESTest works, contributing to better care and support for frail elderly individuals in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants should be able to maintain 10seconds stand feet apart without assistance The Validity of FRAILBESTest in mild cognitive impairment institutionalized patients will be made of subgroup categories: Frail/Non-frail; Cognition preserved/Mild cognitive impairment patients and Institutionalized patients/community living individuals.
- • Frailty will be determine by Fried phenotype Those scoring 3 or more out of 5 will be classify as frail and those scoring 2 or less as non-frail individuals. Mini-Mental State Examination (MMSE) cognition status could be preserved or altered (Score \>24-30).
- • Community living individuals will be non-frail and cognition should preserved they will be assign to Group A.
- • Frail institutionalized individual's (scoring from 24 to 26 at MMSE) will be assign to Group B Frail institutionalized individual's (scoring = or \> to 27 at MMSE) will be assign to Group C Non frail Institutionalized individuals with cognition preserved (scoring = or \> to 27 at MMSE) will be assign to group D.
- Exclusion Criteria:
- • Orthopedic unstable conditions
- • Moderate or severe cognitive status Score \<24 at MMSE
- • Inability to understand indications or communicate with testers.
- • Sustaining severe cardiac, vascular or respiratory diseases or conditions that contraindicate physical activity
- • Presenting a condition for which, in the opinion of the researchers, the evaluation may pose a risk to their health
- • Not having autonomy to decide about their voluntary participation in the study
Trial Officials
María del Pilar Domínguez Oliván, PhD
Principal Investigator
Universidad de Zaragoza
About Instituto De Investigación Sanitaria Aragón
Instituto de Investigación Sanitaria Aragón (IIS Aragón) is a leading clinical research organization dedicated to advancing healthcare through innovative research and collaboration. Based in Spain, IIS Aragón focuses on translational medicine, bridging the gap between laboratory discoveries and clinical applications. The institute fosters a multidisciplinary approach, bringing together experts from various fields to enhance the quality and efficiency of clinical trials. With a commitment to ethical standards and patient safety, IIS Aragón plays a pivotal role in driving scientific advancements and improving health outcomes in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaragoza, , Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0